Alibaba Health Information Technology Dirección
Dirección controles de criterios 3/4
El CEO de Alibaba Health Information Technology es Difan Shen , nombrado en Nov 2023, tiene una permanencia de 3.08 años. compensación anual total es CN¥6.81M, compuesta por 25.2% salario y 74.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.009% de las acciones de la empresa, por valor de HK$5.18M. La antigüedad media del equipo directivo y de la junta directiva es de 2.3 años y 2.3 años, respectivamente.
Información clave
Difan Shen
Chief Executive Officer (CEO)
CN¥6.8m
Compensación total
| Porcentaje del salario del CEO | 25.2% |
| Permanencia del CEO | less than a year |
| Participación del CEO | 0.009% |
| Permanencia media de la dirección | 2.3yrs |
| Promedio de permanencia en la Junta Directiva | 2.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Earnings Tell The Story For Alibaba Health Information Technology Limited (HKG:241) As Its Stock Soars 30%
Oct 18
What Does Alibaba Health Information Technology Limited's (HKG:241) Share Price Indicate?
Sep 23Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital
Jul 03After Leaping 26% Alibaba Health Information Technology Limited (HKG:241) Shares Are Not Flying Under The Radar
Jun 07Alibaba Health Information Technology's (HKG:241) Solid Earnings Are Supported By Other Strong Factors
Jun 06Risks Still Elevated At These Prices As Alibaba Health Information Technology Limited (HKG:241) Shares Dive 26%
Apr 21Is Now The Time To Look At Buying Alibaba Health Information Technology Limited (HKG:241)?
Apr 16Alibaba Health Information Technology (HKG:241) Might Have The Makings Of A Multi-Bagger
Mar 29Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 36% Undervaluation?
Mar 12With A 25% Price Drop For Alibaba Health Information Technology Limited (HKG:241) You'll Still Get What You Pay For
Jan 17Is Now An Opportune Moment To Examine Alibaba Health Information Technology Limited (HKG:241)?
Jan 07Returns On Capital Are Showing Encouraging Signs At Alibaba Health Information Technology (HKG:241)
Dec 15Shareholders Should Be Pleased With Alibaba Health Information Technology Limited's (HKG:241) Price
Sep 28Alibaba Health Information Technology Limited's (HKG:241) Intrinsic Value Is Potentially 25% Below Its Share Price
Jul 02Is Alibaba Health Information Technology Limited (HKG:241) Potentially Undervalued?
Jun 11Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)
Jun 22Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 49% Undervaluation?
Dec 01Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital
Oct 15Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)
Aug 12Alibaba Health Information Technology (HKG:241) Is Doing The Right Things To Multiply Its Share Price
Jun 25These Analysts Just Made A Huge Downgrade To Their Alibaba Health Information Technology Limited (HKG:241) EPS Forecasts
May 30Earnings Report: Alibaba Health Information Technology Limited Missed Revenue Estimates By 6.8%
May 27The Return Trends At Alibaba Health Information Technology (HKG:241) Look Promising
Mar 23Should You Be Adding Alibaba Health Information Technology (HKG:241) To Your Watchlist Today?
Mar 05How Much Are Alibaba Health Information Technology Limited (HKG:241) Insiders Taking Off The Table?
Feb 15Are Alibaba Health Information Technology's (HKG:241) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 31
If You Had Bought Alibaba Health Information Technology (HKG:241) Stock Three Years Ago, You Could Pocket A 457% Gain Today
Dec 31Has Alibaba Health Information Technology Limited's (HKG:241) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Dec 16Will Alibaba Health Information Technology's (HKG:241) Growth In ROCE Persist?
Dec 01Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | CN¥1b |
| Jun 30 2024 | n/a | n/a | CN¥1b |
| Mar 31 2024 | CN¥7m | CN¥2m | CN¥883m |
| Dec 31 2023 | n/a | n/a | CN¥851m |
| Sep 30 2023 | n/a | n/a | CN¥817m |
| Jun 30 2023 | n/a | n/a | CN¥675m |
| Mar 31 2023 | CN¥6m | CN¥1m | CN¥536m |
| Dec 31 2022 | n/a | n/a | CN¥332m |
| Sep 30 2022 | n/a | n/a | CN¥128m |
| Jun 30 2022 | n/a | n/a | -CN¥69m |
| Mar 31 2022 | CN¥6m | CN¥1m | -CN¥266m |
| Dec 31 2021 | n/a | n/a | -CN¥216m |
| Sep 30 2021 | n/a | n/a | -CN¥167m |
| Jun 30 2021 | n/a | n/a | CN¥91m |
| Mar 31 2021 | n/a | n/a | CN¥349m |
| Dec 31 2020 | n/a | n/a | CN¥313m |
| Sep 30 2020 | n/a | n/a | CN¥278m |
| Jun 30 2020 | n/a | n/a | CN¥136m |
| Mar 31 2020 | CN¥12m | CN¥2m | -CN¥7m |
| Dec 31 2019 | n/a | n/a | -CN¥3m |
| Sep 30 2019 | n/a | n/a | CN¥1m |
| Jun 30 2019 | n/a | n/a | -CN¥40m |
| Mar 31 2019 | CN¥7m | CN¥33k | -CN¥82m |
Compensación vs. Mercado: La compensación total ($USD941.64K) de Difan está en línea con el promedio de empresas de tamaño similar en el mercado Hong Kong ($USD868.11K).
Compensación vs. Ingresos: La compensación de Difan ha sido consistente con los resultados de la empresa en el último año.
CEO
Difan Shen (46 yo)
less than a year
Permanencia
CN¥6,814,000
Compensación
Mr. Difan Shen serves as Chief Executive Officer of Alibaba Health Information Technology Limited from November 28, 2023 and serves as Executive Director since October 13, 2021. He was Chief Operating Offi...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Executive Director | less than a year | CN¥6.81m | 0.0089% HK$ 5.2m | |
| CFO & Executive Director | 4.6yrs | CN¥5.34m | 0.0050% HK$ 2.9m | |
| Legal Counsel & Joint Company Secretary | 1.8yrs | sin datos | sin datos | |
| Chief Marketing Officer | 2.7yrs | sin datos | sin datos | |
| Chief People Officer | 4.8yrs | sin datos | sin datos | |
| Financial Controller | no data | sin datos | sin datos | |
| Chief Legal Advisor & Joint Company Secretary | 1.3yrs | sin datos | sin datos |
2.3yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de 241 se considera experimentado (2.3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Executive Director | 3.1yrs | CN¥6.81m | 0.0089% HK$ 5.2m | |
| CFO & Executive Director | 4.1yrs | CN¥5.34m | 0.0050% HK$ 2.9m | |
| Independent Non-Executive Director | 1.3yrs | CN¥411.00k | sin datos | |
| Independent Non-Executive Director | 5.4yrs | CN¥348.00k | sin datos | |
| Non-Executive Chairman of the Board | 4.7yrs | CN¥19.00m | 0.0086% HK$ 5.0m | |
| Independent Non-Executive Director | 1.3yrs | CN¥223.00k | sin datos | |
| Non-Executive Director | 1.5yrs | sin datos | sin datos | |
| Non-Executive Director | 1.1yrs | sin datos | sin datos |
2.3yrs
Permanencia media
48.5yo
Promedio de edad
Junta con experiencia: La junta directiva de 241 no se considera experimentada (2.3 años de permanencia promedio), lo que sugiere una nueva junta directiva.